Articles
 

Study of Immunomodulatory Effects of Arteether Administrated Intratumorally

Abstract

Recent studies have indicated the profound  anti-tumor activity of artemisinin's compounds,  among  which;  arteether  is an  oil-soluble derivative of  artemisinin with an endoperoxide bridge that can induce apoptosis in tumor cells but not in the normal cells.
An experiment was carried out on tumor-bearing Balb/c mice to estimate the effects of Arteether  on  tumor  growth  and  antitumor  immune  responses.  Briefly, 6mg/kg/day  of Arteether and diluents were administered to two groups of mice. Tumor sizes were measured using  digital verniercallipers. Mice were  sacrificed and  splenocytes  were  harvested  for lymphocyte proliferation assay, the level of IL-4 and IFN-γ cytokines, and the percentage of splenic T regulatory cells were measured.
According to the findings, there were no statistical differences between the groups with respect to the level of IFN-γ, IL-4 and proliferation assay; while our results showed that Arteether is effective in the reduction of tumor growth rate.
In general, intra-tumoral injection of Arteether as an oil-soluble derivative of artemisinin brings to light some antitumor properties that may aid in development of more effective antitumor agents.

1. Brossi A, Venugopalan B, Dominguez Gerpe L, Yeh HJ, Flippen-Anderson JL, Buchs P, et al. Arteether, a new antimalarial drug: synthesis and antimalarial properties. J Med Chem 1988;31(3):645-50.
2. Klayman DL. Qinghaosu (artemisinin): an antimalarial drug from China. Science 1985;228(4703):1049-55.
3. Langroudi L, Hassan ZM, Ebtekar M, Mahdavi M, Pakravan M, Noori S. A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T cells in murine breast cancer model. Int Immunopharmacol 2010 ;10(9):1055-61.
4. Sertel S, Eichhorn T, Sieber S, Sauer A, Weiss J, Plinkert PK, et al. Factors determining sensitivity or resistance of tumor cell lines towards artesunate. Chem Biol Interact 2010;185(1):42-52.
5. Lu YY, Chen TS, Qu JL, Pan WL, Sun L, Wei XB. Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells. J Biomed Sci 2009;16:16.
6. Ghantous A, Gali-Muhtasib H,Vuorela H, Saliba NA, Darwiche N. What made sesquiterpene lactones reach cancer clinical trials? Drug Discovery Today 2010;15:668-78.
7. Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 2003 ; 9(12):4404-8.
8. Wang HY, Lee DA, Peng G, Guo Z, Li Y, Kiniwa Y, et al. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 2004;20(1):107-18.
9. Hassan ZM, Yaraee R, Zare N, Ghazanfari T, SarrafNejad AH, Nazori B. Immunomodulatory effect of R10 fraction of garlic extract on natural killer activity. Int Immunopharmacol 2003; 3:1483–9.
10.Noori S, Taghikhani M, Hassan ZM, Allameha A,Mostafaei A. Tehranolide molecule modulates the immune response, reduce regulatory T cell and inhibits tumor growth in vivo. Mol Immunol 2010; 47(7-8):1579-84.
11.From quinine to qinghaosu; historical perspective. SR. From quinine to qinghaosu; historical perspective. IE S, editor. washington DC: ASM; 1998.
12.Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. The anti-malarial artesunate is also active against cancer. Int J Oncol 2001; 18:767-73.
13.Chen H, Zhou HJ, Fang X. Inhibition of human cancer cell line growth and humanu mbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro. Pharmacol Res 2003; 48(3):231–6.
14.Chen H, Sun B, Pan S, Jiang H, Sun X.Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo. AntiCancer Drugs 2009;20(2):131-40.
15.Chen HH, Zhou HJ, Wang WQ, Wu GD. Antimalarial dihydroartemisinin also inhibits angiogenesis. Cancer Chemother Pharmacol 2004; 53(5):423-32.
16.Langroudi L, Hassan ZM, Ebtekar M, Mahdavi M, Pakravan N, Noori S. A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T cells in murine breast cancer model. Int Immunopharmacol 2010; 10(9):1055-61.
17.Zhang YX, Sun HX. Immunosuppressive effect of ethanol extract of Artemisia annua on specific antibody and cellular responses of mice against ovalbumin. Immunopharmacol Immunotoxicol 2009; 31(4):625-30.
18.Tawfik AF, Bishop SJ, Ayalp A, el-Feraly FS. Effects of artemisinin, dihydroartemisinin and arteether on immune responses of normal mice. Inter J Immunopharmacol 1990;12(4):385-9.
19.Farsam V, Hassan ZM, Hosseini AZ, Noori S, Mahdavi M, Ranjbar M. Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4(+) CD25(+) FoxP3(+) T reg cells in vivo. Int Immunopharmacol 2011; 11(11):1802-8.
20.Shakir L, Hussain M, Javeed A. Artemisinins and immune system. Eur J Pharmacol. 2011; 668(1-2):6-14.

Files
IssueVol 12, No 1 (2013) QRcode
SectionArticles
 
Keywords
Anti-tumor Arteether Breast Cancer

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Azimi Mohamadabadi M, Hassan ZM, Zavaran Hosseini A, Noori S, Mahdavi M, Maroufizadeh S, Maroof H. Study of Immunomodulatory Effects of Arteether Administrated Intratumorally. Iran J Allergy Asthma Immunol. 1;12(1):57-62.